What’s happening in our world?
As a global medical consultancy, our team of experts are dedicated to sharing their expertise and knowledge, to bring excellence to the development and use of pharmaceuticals, for the advancement of human health.
June 13, 2026
Clinical trials in Australia: where sponsor teams need support most
Australia continues to attract attention as a destination for early-phase and sponsor-led studies. The reasons are well understood. Faster start-up, a strong clinical research environment and a more efficient pathway into early development all make Australia commercially and operationally attractive. But choosing Australia is not the same as being ready to run well in Australia.…
June 12, 2026
How pharma teams are adding senior medical cover without adding headcount
Across pharma and biotech teams, the conversation is shifting. The challenge is no longer only how to respond once pressure becomes visible. It is how to build enough senior medical capacity into the model before review timelines start to slip, signatory responsibility becomes too concentrated or regional coverage becomes harder to sustain. In many teams,…
March 26, 2026
Where Pharmaceutical Programmes Start to Slow Down
Executive Briefing · March 2026 Where Pharmaceutical Programmes Start to Slow Down Across clinical development, medical affairs and global programme delivery, one issue is showing up more consistently right now. It is rarely a lack of expertise. More often, it is a lack of alignment — and by the time it becomes visible, it is…
November 4, 2025
Reflections on My First AusBiotech Conference.
Dr Manuel Salgado reflects on an inspiring week at AusBiotech 2025, where innovation, collaboration and clinical excellence took centre stage. Discover his key takeaways and how My Medical Department is helping advance high-quality, patient-focused research.
September 30, 2025
Reflections from MAPS-MAPA Australia: People, Partnerships and the Future of Medical Affairs
Navigating the complexities of copy approval in the pharmaceutical industry is no small feat. With stringent regulations and meticulous attention to detail, companies must ensure their promotional and non-promotional materials meet the highest standards of accuracy and compliance. This article helps you navigate the complexities of copy approval.
September 2, 2025
Tackling Peak Conference Demands in Pharma: How MMD Can Support
Navigating the complexities of copy approval in the pharmaceutical industry is no small feat. With stringent regulations and meticulous attention to detail, companies must ensure their promotional and non-promotional materials meet the highest standards of accuracy and compliance. This article helps you navigate the complexities of copy approval.
July 2, 2025
Why Round-the-Clock Medical Monitoring Is Reshaping Clinical Trial Success
Navigating the complexities of copy approval in the pharmaceutical industry is no small feat. With stringent regulations and meticulous attention to detail, companies must ensure their promotional and non-promotional materials meet the highest standards of accuracy and compliance. This article helps you navigate the complexities of copy approval.
June 25, 2025
Expert Insight: Why a Medical Consultancy Is Better Than a Contractor
Navigating the complexities of copy approval in the pharmaceutical industry is no small feat. With stringent regulations and meticulous attention to detail, companies must ensure their promotional and non-promotional materials meet the highest standards of accuracy and compliance. This article helps you navigate the complexities of copy approval.
May 10, 2025
Regulatory Roundup – May 2025
Welcome to the May 2025 edition of our Regulatory Roundup! This month, we bring you the latest updates from key regulatory bodies worldwide, including the Therapeutic Goods Administration (TGA) in Australia, the U.S. Food and Drug Administration (FDA), and the European Medicines Agency (EMA). These updates highlight significant strides in medical regulation, from consultations on…
March 21, 2025
Navigating the Complexities of Copy Approval in the Pharma Industry.
Navigating the complexities of copy approval in the pharmaceutical industry is no small feat. With stringent regulations and meticulous attention to detail, companies must ensure their promotional and non-promotional materials meet the highest standards of accuracy and compliance. This article helps you navigate the complexities of copy approval.
March 18, 2025
Navigating Tax Efficiency for Biotech
When it comes to the biotech industry, tax efficiency is a crucial aspect that can significantly impact a company's bottom line. For biotech firms, the journey from research and development to bringing a product to market is often long and expensive. Our latest article looks at why Australia could be an attractive destination.
February 27, 2025
Trends and Prediciation on The Future of Pharmaceutical Compliance
Explore the future of pharmaceutical compliance in the UK and Australia, focusing on emerging regulations, technological advancements, and evolving compliance services.
February 21, 2025
Case Study: How MMD Provided Seamless, Flexible Medical Support
Discover how My Medical Department (MMD) bridged a critical staffing gap for a leading pharmaceutical company, ensuring compliance and operational continuity during a key transition period. Learn how our expert-led, flexible support can help your team maintain high standards and efficiency.
February 4, 2025
The Crucial Role of Final Signatories in the Pharmaceutical Industry (UK)
The pharmaceutical industry operates under strict regulatory frameworks to ensure that medicines and healthcare products meet the highest standards of safety, efficacy, and compliance. Final signatories are vital in regulated markets—our latest blog delves into the UK market, highlighting the importance of support and collaboration.
February 2, 2025
Case Study: Providing Seamless Global Support for a Leading Biopharmaceutical Company
Enhancing Operational Efficiency and Customer Satisfaction Through Innovative Support Solutions for a Biopharmaceutical company. This case study highlights how our team helped a leading biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines in oncology, cardiovascular, immunology, and fibrosis. Their clinical research and medical departments play a crucial role in driving the success of…